Z8H-48615-16164 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-12-06
Dose 1 — Janssen/Johnson & Johnson
2022-11-15
Dose 2 — Moderna
2022-11-16
Registered in v-safe
2022-11-16
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-11-17
Survey response — days 1–6 daily, dose 2
MedDRA: Chest pain, Dyspnoea — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Acute almost severe Chest pain hard to breathe

MedDRA releases: 2024-11 · check-in free text available
2022-11-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2022-11-20
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2022-12-06
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-12-06	Janssen/Johnson & Johnson	No
2	2022-11-15	Moderna	No

Free text

Release 12 — days 1–6 daily, dose 2

2022-11-17

Systemic reaction (other): Acute almost severe Chest pain hard to breathe

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Chest pain	·	·	✓
SRO	Dyspnoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release